- Home
- LGO vs TLSI Comparison
LGO vs TLSI Comparison
Compare LGO & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- TLSI
- Stock Information
- Founded
- LGO 1988
- TLSI 2010
- Country
- LGO Canada
- TLSI United States
- Employees
- LGO N/A
- TLSI N/A
- Industry
- LGO
- TLSI Medical Specialities
- Sector
- LGO
- TLSI Health Care
- Exchange
- LGO Nasdaq
- TLSI Nasdaq
- Market Cap
- LGO 134.0M
- TLSI 124.9M
- IPO Year
- LGO 2007
- TLSI N/A
- Fundamental
- Price
- LGO $2.03
- TLSI $4.53
- Analyst Decision
- LGO Strong Buy
- TLSI Strong Buy
- Analyst Count
- LGO 1
- TLSI 5
- Target Price
- LGO $4.20
- TLSI $12.10
- AVG Volume (30 Days)
- LGO 225.7K
- TLSI 32.8K
- Earning Date
- LGO 11-12-2024
- TLSI 11-14-2024
- Dividend Yield
- LGO N/A
- TLSI N/A
- EPS Growth
- LGO N/A
- TLSI N/A
- EPS
- LGO N/A
- TLSI N/A
- Revenue
- LGO $144,822,000.00
- TLSI $26,891,000.00
- Revenue This Year
- LGO N/A
- TLSI $61.76
- Revenue Next Year
- LGO $30.88
- TLSI $47.30
- P/E Ratio
- LGO N/A
- TLSI N/A
- Revenue Growth
- LGO N/A
- TLSI 67.92
- 52 Week Low
- LGO $1.38
- TLSI $3.33
- 52 Week High
- LGO $2.84
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- LGO 45.35
- TLSI 58.12
- Support Level
- LGO $1.87
- TLSI $3.74
- Resistance Level
- LGO $2.13
- TLSI $4.66
- Average True Range (ATR)
- LGO 0.16
- TLSI 0.37
- MACD
- LGO -0.04
- TLSI 0.05
- Stochastic Oscillator
- LGO 19.62
- TLSI 88.04
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.